Vitamin D has a preventive effect on liver cancer

Share This Post

Research reports published in the Journal of Cancer Epidemiology, Biomarkers, and Prevention show that there is a negative correlation between circulating 25-hydroxyvitamin D [25 (OH) D] levels and liver cancer risk and chronic liver disease mortality To associate. Gabriel Y. Lai, author of the Department of Cancer Control and Population Science at the National Cancer Institute, and colleagues say that there has been a link between reduced vitamin D levels and chronic liver disease and liver cancer observed in laboratory studies, but there has been little epidemiology Research assesses these associations.

The study included 854 male Finnish smokers who participated in alpha-tocopherol, beta-carotene cancer prevention studies and measured vitamin D levels from their serum samples. During nearly 25 years of follow-up, 202 patients were diagnosed with liver cancer and 225 patients died of liver disease. 427 subjects without liver disease or liver cancer served as controls. Among subjects with a serum 25 (OH) D concentration of less than 10 ng / mL (ng / mL), the risk of liver cancer increased by 91% compared with those with a concentration level greater than 20 ng / mL, chronic The risk of liver disease death increased by 67%.

“Our results suggest that vitamin D may have a preventive effect on liver cancer and chronic liver disease,” Dr. Lai and colleagues concluded. “Future studies need to assess the relationship between vitamin D and liver cancer and liver disease in other populations, especially those with different Risk factors.”

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Seattle Children's Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients
CAR T-Cell therapy

Seattle Children’s Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients

Seattle Children’s Hospital is launching a groundbreaking CAR T-cell clinical trial for pediatric lupus patients. This innovative approach harnesses the body’s immune cells to target and eliminate lupus-affected cells, offering new hope for young patients with this autoimmune disorder. The trial represents a significant advancement in lupus treatment, aiming to improve outcomes and reduce long-term complications for children suffering from this challenging condition.

Efficacy of CAR T Cell Therapy in B-Cell lymphoma Richter Transformation
CAR T-Cell therapy

Efficacy of CAR T Cell Therapy in B-Cell lymphoma Richter Transformation

CAR T cell therapy has shown promising efficacy in treating B-cell lymphoma Richter Transformation, a rare and aggressive disease. This advanced therapy involves genetically modifying a patient’s T cells to target and destroy cancerous B cells. Clinical trials indicate significant response rates, with some patients achieving complete remission. Despite challenges like potential severe side effects, CAR T cell therapy represents a groundbreaking approach, offering hope for improved outcomes in this difficult-to-treat condition.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy